Načítá se...

O4.08 AGI5198, AN INHIBITOR OF IDH1R132H, PROTECTS IDH1R132H HCT116 CELLS AGAINST IRRADIATION

BACKGROUND: IDH1(R132H) mutations are both inaugural events in the formation of glioma and associated with prolonged glioma patient survival. The IDH1(R132H) mutation confers a neo-enzymatic function that results in accumulation of the oncometabolite D-2-hydroxyglutarate (D-2HG), which promotes glio...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Molenaar, R.J., Dimitrakopoulou, D., Stap, J., Bleeker, F.E., Van Noorden, C.J.F.
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185649/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.29
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!